Hornig Appointed Executive Chairman; Caruolo Appointed Lead Independent Director
PALM HARBOR, Fla., July 08, 2026 (GLOBE NEWSWIRE) -- Polomar Health Services, Inc. (OTCQB: PMHS) ("Polomar" or the "Company"), a healthcare services company operating a specialty compounding pharmacy and prescription-fulfillment platform, today announced changes to its Board of Directors as the Company advances its growth strategy.
Effective July 1, 2026, George Hornig has been appointed Executive Chairman of the Board of Directors. George Caruolo has joined the Board and will serve as Lead Independent Director. Additionally, Gabrielle Toledano and Alexandra Peterson have joined the Board, while Gabriel Del Virginia will continue to serve as a member.
The strengthened Board leadership brings additional experience in public-company governance, capital markets, operating strategy, healthcare, and regulatory matters. Polomar is also reviewing its commercial priorities, product mix, and operating roadmap, and expects to provide a broader business update following the completion of that review.
"I look forward to working with the new members of our expanded Board in implementing our strategic initiatives and vision for continued growth, focusing on products that promote overall health, wellness and longevity," said Terrence M. Tierney, Interim Chief Executive Officer of Polomar.
"Polomar is entering an important new chapter, and I am pleased to join the Company as Executive Chairman," said George Hornig. "The Board will work closely with management to build on Polomar's existing healthcare services platform, refine its commercial priorities, and pursue the opportunities that offer the greatest potential for long-term value creation. Our focus will be on disciplined execution, strong governance, and positioning the Company for sustainable growth."
Board Leadership
George Hornig, Executive Chairman, has extensive experience serving on the boards of public and private companies. He is Managing Partner and Co-Founder of The Seed Lab and previously served as Chairman of Xometry, Co-Chairman and Audit Chair of Healthwell Acquisition Corp., and a director of Syntax Advisors. His earlier career included senior leadership roles at PineBridge Investments, Credit Suisse Asset Management, and Deutsche Bank Americas. He holds A.B., J.D., and M.B.A. degrees from Harvard University.
George Caruolo, Lead Independent Director, is an attorney and advisor with extensive experience in governance, public service, and government affairs. He previously served in the Rhode Island House of Representatives, including as Majority Leader. He has served on numerous boards, commissions, and audit committees, including the Board of Directors of Lifespan, Inc. and the Rhode Island Board of Regents for Elementary and Secondary Education, where he served as Chair.